atrasentan has been researched along with natriuretic peptide, brain in 4 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | atrasentan (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianciotti, LG; De Bold, AJ | 2 |
| Andress, D; Brennan, JJ; Coll, B; Correa-Rotter, R; de Zeeuw, D; Hou, FF; Kitzman, DW; Kohan, DE; Lambers Heerspink, HJ; Makino, H; Parving, HH; Perkovic, V; Remuzzi, G; Tobe, SW; Toto, R | 1 |
| Bakris, GL; Correa-Rotter, R; de Zeeuw, D; Heerspink, HJL; Hou, FF; Januzzi, JL; Kitzman, DW; Kohan, DE; Kolansky, DM; Koomen, J; Makino, H; McMurray, JJV; Parving, HH; Perkovic, V; Smeijer, JD; Tobe, S | 1 |
2 trial(s) available for atrasentan and natriuretic peptide, brain
| Article | Year |
|---|---|
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy.
Topics: Aged; Albuminuria; Atrasentan; Body Fluids; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Endothelin Receptor Antagonists; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrrolidines; Weight Gain | 2015 |
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure.
Topics: Atrasentan; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Natriuretic Peptide, Brain; Renal Insufficiency, Chronic; Weight Gain | 2022 |
2 other study(ies) available for atrasentan and natriuretic peptide, brain
| Article | Year |
|---|---|
Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension.
Topics: Animals; Atrasentan; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Desoxycorticosterone; Endothelin Receptor Antagonists; Gene Expression Regulation; Heart; Heart Ventricles; Hypertension; Male; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium, Dietary; Transcription, Genetic | 2000 |
Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
Topics: Analysis of Variance; Animals; Atrasentan; Atrial Natriuretic Factor; Blotting, Northern; Collagen; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression Regulation; Heart Atria; Heart Ventricles; Hypertension, Renovascular; Male; Natriuretic Peptide, Brain; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger | 2001 |